NCT05370209View on ClinicalTrials.gov

Performance and Safety of Otinova® Ear Spray

NATerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

November 27, 2023

Study Completion Date

January 29, 2024

Conditions
Otitis Externa
Interventions
DEVICE

Otinova® Ear Spray

Ear spray

Trial Locations (3)

Unknown

Carlanderska sjukhuset, Gothenburg

Cordinator Medical Service AB, Linköping

Öron-Näsa-Hals-Center Malmö, Malmo

Sponsors

Lead Sponsor

Circius Pharma AB
All Listed Sponsors
lead

Circius Pharma AB

INDUSTRY

NCT05370209 - Performance and Safety of Otinova® Ear Spray | Biotech Hunter | Biotech Hunter